Literature DB >> 34598999

A Novel Long Noncoding RNA Finetunes the DNA Damage Response in Hepatocellular Carcinoma.

Marina Barcena-Varela1,2,3,4,5, Amaia Lujambio6,2,3,4,5,7.   

Abstract

The study by Unfried and colleagues reports the intriguing discovery of a novel long noncoding RNA (lncRNA) with a critical role in the regulation of DNA damage response in hepatocellular carcinoma. Providing an exhaustive and detailed characterization of the complex network interactions within the double-stranded breaks in the DNA, the authors demonstrated that NIHCOLE serves as a scaffold and facilitator of nonhomologous end-joining machinery. This study greatly contributes to the growing evidence supporting the key roles of ncRNAs in health and disease. Although larger studies are needed to understand the potential of lncRNAs to improve the clinical management of patients with cancer, this study demonstrates that high expression of NIHCOLE may be associated with an impaired response to DNA damage-based therapies, in part through its role in preventing cell death.See related article by Unfried et al., p. 4910. ©2021 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34598999     DOI: 10.1158/0008-5472.CAN-21-2776

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  1 in total

1.  RNA-binding protein ZCCHC4 promotes human cancer chemoresistance by disrupting DNA-damage-induced apoptosis.

Authors:  Ha Zhu; Kun Chen; Yali Chen; Juan Liu; Xiaomin Zhang; Yumei Zhou; Qiuyan Liu; Bingjing Wang; Taoyong Chen; Xuetao Cao
Journal:  Signal Transduct Target Ther       Date:  2022-07-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.